Cell Therapy and Beta-Cell Regeneration
While not a "wearable," the most advanced diabetes "device" of 2026 is the Bioprinted Cell Implant.
Zimislecel: An experimental infusion of lab-grown, stem-cell-derived beta cells that can survive in the body without anti-rejection drugs.
Sana UP421 Study: 2026 human trials show these cells can successfully produce insulin in response to blood sugar, offering hope for a one-time treatment that could eliminate the need for external insulin.
1 View